Sell

VRTX Quote, Financials, Valuation and Earnings

Last price:

$405.10

Seasonality move :

6.89%

Day range:

$386.49 - $401.31

52-week range:

$377.85 - $519.88

Dividend yield:

0%

P/E ratio:

25.59x

P/S ratio:

9.73x

P/B ratio:

6.55x

Volume:

6M

Avg. volume:

1.7M

1-year change:

-0.74%

Market cap:

$102.3B

Revenue:

$9.9B

EPS (TTM):

-$1.99

Vertex Pharmaceuticals SEC Filings

Company	Filed	Form Type	Description
VRTX Vertex Pharmaceuticals	05/07/2024	10-Q	10-Q filing on 05/07/2024	View Form
VRTX Vertex Pharmaceuticals	02/15/2024	10-K	10-K filing on 02/15/2024	View Form
VRTX Vertex Pharmaceuticals	11/07/2023	10-Q	10-Q filing on 11/07/2023	View Form
VRTX Vertex Pharmaceuticals	08/02/2023	10-Q	10-Q filing on 08/02/2023	View Form
VRTX Vertex Pharmaceuticals	05/02/2023	10-Q	10-Q filing on 05/02/2023	View Form
VRTX Vertex Pharmaceuticals	02/10/2023	10-K	10-K filing on 02/10/2023	View Form
VRTX Vertex Pharmaceuticals	10/28/2022	10-Q	10-Q filing on 10/28/2022	View Form
VRTX Vertex Pharmaceuticals	08/05/2022	10-Q	10-Q filing on 08/05/2022	View Form
VRTX Vertex Pharmaceuticals	05/06/2022	10-Q	10-Q filing on 05/06/2022	View Form
VRTX Vertex Pharmaceuticals	02/09/2022	10-K	10-K filing on 02/09/2022	View Form
VRTX Vertex Pharmaceuticals	11/03/2021	10-Q	10-Q filing on 11/03/2021	View Form
VRTX Vertex Pharmaceuticals	07/30/2021	10-Q	10-Q filing on 07/30/2021	View Form
VRTX Vertex Pharmaceuticals	04/30/2021	10-Q	10-Q filing on 04/30/2021	View Form
VRTX Vertex Pharmaceuticals	02/11/2021	10-K	10-K filing on 02/11/2021	View Form
VRTX Vertex Pharmaceuticals	10/30/2020	10-Q	10-Q filing on 10/30/2020	View Form
VRTX Vertex Pharmaceuticals	07/31/2020	10-Q	10-Q filing on 07/31/2020	View Form
VRTX Vertex Pharmaceuticals	05/01/2020	10-Q	10-Q filing on 05/01/2020	View Form
VRTX Vertex Pharmaceuticals	02/13/2020	10-K	10-K filing on 02/13/2020	View Form
VRTX Vertex Pharmaceuticals	10/31/2019	10-Q	10-Q filing on 10/31/2019	View Form
VRTX Vertex Pharmaceuticals	08/01/2019	10-Q	10-Q filing on 08/01/2019	View Form
VRTX Vertex Pharmaceuticals	05/01/2019	10-Q	10-Q filing on 05/01/2019	View Form
VRTX Vertex Pharmaceuticals	02/13/2019	10-K	10-K filing on 02/13/2019	View Form
VRTX Vertex Pharmaceuticals	10/25/2018	10-Q	10-Q filing on 10/25/2018	View Form
VRTX Vertex Pharmaceuticals	07/26/2018	10-Q	10-Q filing on 07/26/2018	View Form
VRTX Vertex Pharmaceuticals	04/27/2018	10-Q	10-Q filing on 04/27/2018	View Form
VRTX Vertex Pharmaceuticals	02/15/2018	10-K	10-K filing on 02/15/2018	View Form
VRTX Vertex Pharmaceuticals	10/30/2017	10-Q	10-Q filing on 10/30/2017	View Form
VRTX Vertex Pharmaceuticals	07/28/2017	10-Q	10-Q filing on 07/28/2017	View Form
VRTX Vertex Pharmaceuticals	04/28/2017	10-Q	10-Q filing on 04/28/2017	View Form
VRTX Vertex Pharmaceuticals	02/23/2017	10-K	10-K filing on 02/23/2017	View Form
VRTX Vertex Pharmaceuticals	10/31/2016	10-Q	10-Q filing on 10/31/2016	View Form
VRTX Vertex Pharmaceuticals	08/01/2016	10-Q	10-Q filing on 08/01/2016	View Form
VRTX Vertex Pharmaceuticals	05/03/2016	10-Q	10-Q filing on 05/03/2016	View Form
VRTX Vertex Pharmaceuticals	02/16/2016	10-K	10-K filing on 02/16/2016	View Form
VRTX Vertex Pharmaceuticals	10/30/2015	10-Q	10-Q filing on 10/30/2015	View Form
VRTX Vertex Pharmaceuticals	08/04/2015	10-Q	10-Q filing on 08/04/2015	View Form
VRTX Vertex Pharmaceuticals	05/04/2015	10-Q	10-Q filing on 05/04/2015	View Form
VRTX Vertex Pharmaceuticals	02/13/2015	10-K	10-K filing on 02/13/2015	View Form

Related Companies

Get VRTX Stock Alert

Signup to receive the latest stock alerts

Financial Ratios

VRTX

Sector

P/E ratio

25.59x

25.86x

PEG ratio

1.13x

0.00x

P/B ratio

6.55x

1.84x

Price / LTM sales

9.73x

1.86x

Growth Metrics

VRTX

Sector

Revenue growth

11.61%

7.1%

Earnings growth

1.01%

1.82%

Revenue (5-year growth)

26.49%

8.72%

Earnings forecast

$4.13

-$0.20

Profitability

VRTX

Sector

Profitability FY 2023

$8.6B

$57.1M

Return on invested capital

-2.89%

-14.09%

Return on assets

-2.17%

-11.79%

Return on equity

-2.89%

-14.85%

Earnings Date

Last Earnings Date

Nov

4

Next Earnings Date

Feb

5

Estimated Next Earnings Date

Feb

3

Balance Sheet

VRTX

Sector

Total cash

$6.5B

$46.9M

Short term investments

$849.2M

$44M

Total assets

$22.7B

$142M

Long term debt

--

$6.5M

Stock Ideas

Buy

64

Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy or Sell?

Buy

52

Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy or Sell?

Buy

55

Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Buy or Sell?

Alerts

Buy

61

QMCO alert for Dec 23

Quantum [QMCO] is up 3.65% over the past day.

Buy or Sell?

Sell

46

NUKK alert for Dec 23

Nukkleus [NUKK] is up 4.9% over the past day.

Buy or Sell?

Sell

1

IIPR alert for Dec 23

Innovative Industrial Properties [IIPR] is down 4.4% over the past day.

Buy or Sell?

Master Safe Stock Market Strategies

Get Paid To Own Stocks. Insure Your Stocks During Downtrends. Master "The Vacation Trade".

Vertex Pharmaceuticals SEC Filings

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Related Companies

Get VRTX Stock Alert

Financial Ratios

Growth Metrics

Profitability

Earnings Date

Balance Sheet

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

NVIDIA vs Broadcom Stock: Which Is Best?

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

Will Tyson Foods Stock Bounce Back?

Stock Ideas

Is AAPL Stock a Buy?

Is NVDA Stock a Buy?

Is MSFT Stock a Buy?

Alerts

QMCO alert for Dec 23

NUKK alert for Dec 23

IIPR alert for Dec 23

THE #1 STOCK ANALYSIS TOOLTO MAKE SMARTER BUY AND SELL DECISIONS

Watchlist

Stock Score

Seasonality

Analyze

Covered Calls

Valuation

Smart Money

Education

E-Book

Newsletters

Companies

Dividends

Traders Library

Big Movers

Stock Ideas

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS